查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1781946

人體微生物組市場，按產品、按疾病、按類型、按給藥途徑、按最終用戶、按國家和地區 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率和預測

Human Microbiome Market, By Product, By Diseases, By Type, By Route of Administration, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 260 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年人類微生物組市場規模價值 8.219 億美元，2025 年至 2032 年的複合年成長率為 31.20%。

人類微生物組市場-市場動態

慢性病盛行率上升推動市場需求

肥胖、糖尿病和發炎性腸道疾病 (IBD) 等慢性疾病的發病率不斷上升，推動了對基於微生物組的療法的需求。根據《2023 年世界肥胖地圖集》，全球約 31.2 億人（佔人口的 38%）超重或肥胖。此外，大量的政府資金投入正在加速微生物組科學的進步，從而推動全球人類微生物組市場的成長。然而，高昂的研發成本和嚴格的監管框架可能會在預測期內阻礙市場成長。相反，對個人化醫療保健的日益重視為基於微生物組的診斷和針對個別微生物組特徵的治療提供了機會。

人類微生物組市場-關鍵見解

根據我們的研究分析師的分析，預測期內（2025-2032 年）全球市場預計年複合成長率約為 31.20%

根據產品細分，益生菌預計在 2024 年佔據最大市場佔有率

根據疾病細分，胃腸道疾病是 2024 年的主要疾病

根據類型細分，活體生物治療產品 (LBP) 是 2024 年的主要類型

按地區分類，北美是 2024 年的主要收入來源

人類微生物組市場-細分分析：

全球人類微生物組市場根據產品、疾病、類型、給藥途徑、最終用戶和地區進行細分。

根據產品類型，市場分為四大類：益生元、益生菌、藥物和共生元。預計在預測期內，益生菌將在全球人類微生物組市場中佔據最大佔有率。這種主導地位的形成歸因於消費者對益生菌對腸道健康、免疫力和整體健康的益處的認知不斷提高。

依疾病類型，市場可分為四類：胃腸道疾病、傳染病、內分泌及代謝性紊亂等疾病。其中，胃腸道疾病預計將佔據最大的市場佔有率。這種主導地位歸因於腸躁症 (IBS)、發炎性腸道疾病 (IBD)、乳糜瀉和胃食道逆流症 (GERD) 等胃腸道疾病的盛行率較高。

人類微生物組市場—地理洞察

北美地區佔據全球人類微生物組市場的最大佔有率。這種優勢歸功於其完善的醫療基礎設施、對微生物組研究的大量投入以及慢性病的高發病率。此外，預計亞太地區在預測期內將經歷人類微生物組市場最快的成長。這項快速擴張的驅動力源於人們對微生物組健康的認知不斷提高、個人化醫療需求的不斷成長以及測序技術的進步。

人類微生物組市場-競爭格局：

人們對個人化醫療和基於微生物組的療法日益成長的興趣，正推動這一新興領域的企業之間展開激烈競爭。產業參與者正致力於與研究機構和醫療保健提供者建立策略合作，以加速產品開發。許多公司正在大力投資研發，以發現基於微生物組的新型診斷方法和治療方法。此外，各公司正在申請專利並簽訂授權協議，以增強其產品線。向尚未開發的地區擴張以及開發以消費者為導向的微生物組產品也是關鍵的競爭策略。

最新動態：

2025 年 2 月，Seres Therapeutics 推出了 SER-109，這是美國首個獲得 FDA 批准的微生物組療法，旨在透過使用活細菌孢子恢復腸道菌群來治療復發性艱難梭菌感染。

目錄

第1章：人類微生物組市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • 人類微生物組市場（按產品）片段
    • 人類微生物組市場（按疾病）
    • 人類微生物組市場片段（按類型）
    • 人類微生物組市場依給藥途徑分類
    • 人類微生物組市場片段（按最終用戶）
    • 人類微生物組市場（按國家/地區）
    • 人類微生物組市場（按地區）
  • 競爭洞察

第3章：人類微生物組關鍵市場趨勢

  • 人類微生物組市場促進因素
    • 市場促進因素的影響分析
  • 人類微生物組市場限制
    • 市場限制的影響分析
  • 人類微生物組市場機遇
  • 人類微生物組市場未來趨勢

第4章：人類微生物組產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：人類微生物組市場：地緣政治緊張局勢升級的影響

  • COVID-19 疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：人類微生物組市場模式

  • 2024年人類微生物組市場佔有率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：人體微生物組市場－依產品

  • 概述
    • 按產品細分的市佔率分析
    • 益生菌
    • 藥物
    • 合生元

第 8 章：人類微生物組市場 - 按疾病

  • 概述
    • 按疾病細分的佔有率分析
    • 胃腸道疾病
    • 傳染病
    • 內分泌與代謝紊亂
    • 其他疾病

第9章：人體微生物組市場－依類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 活體生物治療產品（LBP）
    • 細菌合併移植（BCT）/糞便微生物移植（FMT）
    • 其他微生物組類型

第 10 章：人體微生物組市場 - 按給藥途徑

  • 概述
    • 按給藥途徑分類的細分市佔率分析
    • 直腸
    • 口服

第 11 章：人類微生物組市場 - 按最終用戶

  • 概述
    • 按最終用戶細分的佔有率分析
    • 長期照護機構
    • 醫院和診所
    • 其他

第 12 章：人類微生物組市場 - 按地區分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美人體微生物組主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模及預測（按產品）
    • 北美市場規模及預測（依疾病分類）
    • 北美市場規模和預測（按類型）
    • 北美市場規模及預測（按給藥途徑）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲人體微生物組主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模及預測（按產品）
    • 歐洲市場規模及預測（依疾病分類）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模及預測（依管理途徑）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區人體微生物組主要製造商
    • 亞太地區市場規模及預測（依國家）
    • 亞太地區市場規模及預測（依產品）
    • 亞太地區市場規模及預測（依疾病分類）
    • 亞太地區市場規模及預測（按類型）
    • 亞太地區市場規模及預測（依管理途徑）
    • 亞太地區市場規模及預測（依最終用戶）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲人體微生物組主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（按產品）
    • 拉丁美洲市場規模及預測（依疾病分類）
    • 拉丁美洲市場規模及預測（按類型）
    • 拉丁美洲市場規模及預測（依管理途徑）
    • LATAM 規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲人體微生物組主要製造商
    • 中東和非洲市場規模及預測（按國家/地區）
    • 中東和非洲市場規模及預測（按產品）
    • 中東和非洲市場規模及預測（依疾病分類）
    • 中東和非洲市場規模和預測（按類型）
    • 中東和非洲市場規模及預測（按管理途徑）
    • 中東和非洲市場規模及預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 13 章：關鍵供應商分析-人類微生物組產業

  • 競爭儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • ENTEROME
    • Pendulum
    • DuPont
    • Yakult USA Inc.
    • Metabiomics
    • Vedanta Biosciences, Inc.
    • Optibiotix Health plc
    • Microbiome Therapeutics Innovation Group
    • BioHM Health
    • Osel, Inc.
    • Seres Therapeutics
    • Infinant Health Inc.
    • Merck & Co., Inc.
    • Theriva Biologics
    • Qualigen Therapeutics, Inc.
    • Synlogic
    • Symbiotix, LLC
    • Resbiotic
    • Symberix, Inc.
    • Exegi Pharma Inc.
    • Seed Health Inc.
    • Biogaia AB
    • BiomeBank
    • Ferring Pharmaceuticals
    • Others

第 14 章：360 度分析師視角

第 15 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5432

REPORT HIGHLIGHT

Human microbiome market size was valued at US$ 821.90 Million in 2024, expanding at a CAGR of 31.20% from 2025 to 2032.

The human microbiome refers to the diverse community of microorganisms, including bacteria, viruses, fungi, and other microbes, that inhabit various parts of the human body such as the gut, skin, mouth, and respiratory tract. These microorganisms play a vital role in maintaining health by aiding digestion, supporting the immune system, and protecting against pathogens. Disruptions in the microbiome balance are linked to various diseases, including obesity, diabetes, and autoimmune disorders.

Human Microbiome Market- Market Dynamics

Increasing prevalence of chronic diseases to propel market demand

The increasing incidence of chronic conditions such as obesity, diabetes, and inflammatory bowel disease (IBD) is propelling the demand for microbiome-based therapies. According to the World Obesity Atlas 2023, 38% of the global population, approximately 3.12 billion people are overweight or obese. In addition, substantial government funding is accelerating advancements in microbiome science, which is driving the growth of the global human microbiome market. However, high cost of R&D and stringent regulatory frameworks may hamper the market growth during the forecast period. On the contrary, the growing emphasis on personalized healthcare presents opportunities for microbiome-based diagnostics and treatments tailored to individual microbiota profiles.

Human Microbiome Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 31.20% over the forecast period (2025-2032)

Based on Product segmentation, probiotics was predicted to show maximum market share in the year 2024

Based on Diseases segmentation, gastrointestinal was the leading Diseases in 2024

Based on Type segmentation, live biotherapeutic products (LBP) was the leading Type in 2024

On the basis of region, North America was the leading revenue generator in 2024

Human Microbiome Market- Segmentation Analysis:

The Global Human Microbiome Market is segmented on the basis of Product, Diseases, Type, Route of Administration, End-user, and Region.

The market is divided into four categories based on Product: prebiotics, probiotics, drugs, and sybnbiotics. The probiotics segment is anticipated to hold the largest market share in the global human microbiome market during the forecast period. This dominance is attributed to increasing consumer awareness of the benefits of probiotics for gut health, immunity, and overall wellness.

The market is divided into four categories based on Diseases: gastrointestinal diseases, infectious diseases, endocrine & metabolic disorders, and other diseases. Among these, the gastrointestinal diseases segment is anticipated to hold the largest market share in the market. This dominance is attributed to the high prevalence of gastrointestinal conditions such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), celiac disease, and gastroesophageal reflux disease (GERD).

Human Microbiome Market- Geographical Insights

The North America region holds the largest share of the global human microbiome market. This dominance is attributed to a well-established healthcare infrastructure, significant investments in microbiome research, and a high prevalence of chronic diseases. Besides, the Asia-Pacific region is projected to experience the fastest growth in the human microbiome market during the forecast period. This rapid expansion is driven by increasing awareness of microbiome health, rising demand for personalized medicine, and advancements in sequencing technologies.

Human Microbiome Market- Competitive Landscape:

Rising interest in personalized medicine and microbiome-based therapies is driving intense competition among companies in this emerging field. Industry participants are focusing on strategic collaborations with research institutions and healthcare providers to accelerate product development. Many are investing heavily in R&D to discover novel microbiome-based diagnostics and therapeutics. Additionally, companies are securing patents and engaging in licensing agreements to strengthen their pipelines. Expansion into untapped regions and the development of consumer-targeted microbiome products also form key competitive strategies.

Recent Developments:

In February 2025, Seres Therapeutics launched SER-109, the first FDA-approved microbiome therapy in the U.S., designed to treat recurrent C. difficile infection by restoring gut microbiota using live bacterial spores.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HUMAN MICROBIOME MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • ENTEROME
  • Pendulum
  • DuPont
  • Yakult U.S.A. Inc.
  • Metabiomics
  • Vedanta Biosciences, Inc.
  • Optibiotix Health plc
  • Microbiome Therapeutics Innovation Group
  • BioHM Health
  • Osel, Inc.
  • Seres Therapeutics
  • Infinant Health Inc.
  • Merck & Co., Inc.
  • Theriva Biologics
  • Qualigen Therapeutics, Inc.
  • Synlogic
  • Symbiotix, LLC
  • Resbiotic
  • Symberix, Inc.
  • Exegi Pharma Inc.
  • Seed Health Inc.
  • Biogaia AB
  • BiomeBank
  • Ferring Pharmaceuticals
  • Others

GLOBAL HUMAN MICROBIOME MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Prebiotics
  • Drugs
  • Synbiotics

GLOBAL HUMAN MICROBIOME MARKET, BY DISEASES- MARKET ANALYSIS, 2019 - 2032

  • Gastrointestinal Diseases
  • Infectious Diseases
  • Endocrine & Metabolic Disorders
  • Other Diseases

GLOBAL HUMAN MICROBIOME MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Live Biotherapeutic Products (LBP)
  • Bacterial Consortia Transplantation (BCT) / Fecal Microbiota Transplantation (FMT)
  • Other Microbiome Types

GLOBAL HUMAN MICROBIOME MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Rectal
  • Oral

GLOBAL HUMAN MICROBIOME MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Long-term Care Facilities
  • Hospitals & Clinics
  • Others

GLOBAL HUMAN MICROBIOME MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Human Microbiome Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Human Microbiome Market Snippet by Product
    • 2.1.2. Human Microbiome Market Snippet by Diseases
    • 2.1.3. Human Microbiome Market Snippet by Type
    • 2.1.4. Human Microbiome Market Snippet by Route of Administration
    • 2.1.5. Human Microbiome Market Snippet by End User
    • 2.1.6. Human Microbiome Market Snippet by Country
    • 2.1.7. Human Microbiome Market Snippet by Region
  • 2.2. Competitive Insights

3. Human Microbiome Key Market Trends

  • 3.1. Human Microbiome Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Human Microbiome Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Human Microbiome Market Opportunities
  • 3.4. Human Microbiome Market Future Trends

4. Human Microbiome Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Human Microbiome Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Human Microbiome Market Landscape

  • 6.1. Human Microbiome Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Human Microbiome Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Probiotics
    • 7.1.3. Drugs
    • 7.1.4. Synbiotics

8. Human Microbiome Market - By Diseases

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Diseases, 2024 & 2032 (%)
    • 8.1.2. Gastrointestinal Diseases
    • 8.1.3. Infectious Diseases
    • 8.1.4. Endocrine & Metabolic Disorders
    • 8.1.5. Other Diseases

9. Human Microbiome Market - By Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 9.1.2. Live Biotherapeutic Products (LBP)
    • 9.1.3. Bacterial Consortia Transplantation (BCT) / Fecal Microbiota Transplantation (FMT)
    • 9.1.4. Other Microbiome Types

10. Human Microbiome Market - By Route of Administration

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Route of Administration, 2024 & 2032 (%)
    • 10.1.2. Rectal
    • 10.1.3. Oral

11. Human Microbiome Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 11.1.2. Long-term Care Facilities
    • 11.1.3. Hospitals & Clinics
    • 11.1.4. Others

12. Human Microbiome Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Human Microbiome Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Human Microbiome Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Human Microbiome Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Human Microbiome Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Human Microbiome Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Human Microbiome Industry

  • 13.1. Competitive Dashboard
    • 13.1.1. Competitive Benchmarking
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. ENTEROME
    • 13.2.2. Pendulum
    • 13.2.3. DuPont
    • 13.2.4. Yakult U.S.A. Inc.
    • 13.2.5. Metabiomics
    • 13.2.6. Vedanta Biosciences, Inc.
    • 13.2.7. Optibiotix Health plc
    • 13.2.8. Microbiome Therapeutics Innovation Group
    • 13.2.9. BioHM Health
    • 13.2.10. Osel, Inc.
    • 13.2.11. Seres Therapeutics
    • 13.2.12. Infinant Health Inc.
    • 13.2.13. Merck & Co., Inc.
    • 13.2.14. Theriva Biologics
    • 13.2.15. Qualigen Therapeutics, Inc.
    • 13.2.16. Synlogic
    • 13.2.17. Symbiotix, LLC
    • 13.2.18. Resbiotic
    • 13.2.19. Symberix, Inc.
    • 13.2.20. Exegi Pharma Inc.
    • 13.2.21. Seed Health Inc.
    • 13.2.22. Biogaia AB
    • 13.2.23. BiomeBank
    • 13.2.24. Ferring Pharmaceuticals
    • 13.2.25. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us